Adoptive immunotherapy with tumor-infiltrating T lymphocytes - Simon Turcotte

Sept 12th, 2022 - Adoptive immunotherapy with tumor-infiltrating T lymphocytes: developing new cell products and initiating a clinical program for solid cancer patients - Simon Turcotte, MD, MSc, FRCSC

[@insertname5421]

What are you guys waiting to bring this to market really?

[@em34ev3r]

very good point. People need this now.